Lexicon Pharmaceuticals, Inc. to Cut 102 Jobs THE WOODLANDS, Texas, Jan. 22, 2009 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NasdaqGM:LXRX - News), a biopharmaceutical company focused on ...

(RTTNews) - Shares of Lexicon Pharmaceuticals, Inc. (LXRX) are currently gaining over 35% after the company said it received a regulatory feedback that clears a key hurdle for partnership ...

Lexicon Pharmaceuticals, Inc. LXRX announced positive top-line data from a phase III study, TELECAST, on its pipeline candidate, telotristat etiprate.

DALLAS, Jan. 7, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Lexicon Pharmaceuticals Inc. (Nasdaq:LXRX). The report includes financial, comparative and ...

THE WOODLANDS, Texas, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced it has received a complete response letter (CRL) from the U.S. Food and Drug ...

THE WOODLANDS, Texas, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced topline data from the Phase 3 SOTA-EMPA study for sotagliflozin (Zynquista ...

To give an assist to those not quite on the hip, IGN Comics has launched the Lexicon. We'll clear up the characters, locations and terms that can prove the most confusing to fans. Check back often ...

Before RILEY, Chief Judge, MELLOY and COLLOTON, Circuit Judges. Lexicon, Inc. built a battery of silos for Nu-Iron Unlimited in the West Indies. Months after completion, one of the silos collapsed ...

Lexicon, which has 50 full-time employees and annual revenue of $14 million, landed in the No. 4 spot on last year's Inc. 500, with three-year growth of more than 14,000 percent.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 revenue is $2.93 million, and the earnings are expected to come ...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript May 5, 2024 Lexicon Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2025 Earnings Call Transcript May 13, 2025 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.1.